According to Acasti Pharma latest financial reports the cash on hand of ACST is $27.89M, an decrease of -36.12% to 2022. At the end of 2022 company had $43.66M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $27.89M | -36.12% |
2022 | $43.66M | -28.11% |
2021 | $60.73M | 326.48% |
2020 | $14.24M | -24.72% |
2019 | $18.92M | - |